No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo

European Journal of Neuroscience

Volumn 12, Issue 7, 2000, Pages 2235-2242

  Lendon, Corinne L ^a,b   Han, Byung Hee ^b   Salimi, Kayvon ^b   Fagan, Anne M ^b   Behrens, Maria I ^b,c   Muller, Maureen C ^b   Holtzman, David M ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL DR SÓTERO DEL RÍO   (Chile)

Author keywords

Alzheimer's disease; Culture; Injury; Murine; Transgenic

Indexed keywords

APOLIPOPROTEIN E; EXCITOTOXIN; GLUTAMATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID; STAUROSPORINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; MOUSE; NERVE CELL NECROSIS; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; APOPTOSIS; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MICE; MICE, INBRED CBA; MICE, KNOCKOUT; N-METHYLASPARTATE; NEURONS; NEUROTOXINS; STAUROSPORINE;

EID: 0033915857     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00113.x     Document Type: Article

References (55)

1. Alberts, M.J., Graffagnino, C., McClenny, C., DeLong, D., Strittmatter, W., Saunders, A.M. & Roses, A.D. (1995) ApoE genotype and survival from intracerebral hemorrhage. Lancet, 346, 575.
2. Anderson, R., Barnes, J.C., Bliss, T.V., Cain, D.P, Cambon, K., Davies, H.A., Errington, M.L., Fellows, L.A., Gray, R.A., Hoh, T., Stewart, M., Large, C.H. & Higgins, G.A. (1998) Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience, 85(1), 93-110.
3. Berry, M & Logan, A. (1999) The response of the CNS to penetrant injury: scarring and regeneration of axons. In Crockard, A., Hayward, R. & Hoff, J. (eds) Neurosurgery: The Scientific Basis of Clinical Practice, 3rd edition. Blackwell Science, Oxford, UK, pp. 479-498.
4. Boyles, J.K., Pitas, R.E., Wilson, E., Mahley, R.W. & Taylor, J.M. (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest., 76, 1501-1513.
5. Buttini, M., Orth, M., Bellosta, S., Akeefe. H., Pitas, R.E., Wyss-Coray, T., Mucke, L. & Mahley, R.W. (1999) Expression of human apolipoprotein E3 or E4 in the brains of ApoE -/-mice: isoform-speciflc effects on neurodegeneration. J Neuroscience, 19(12), 4867-4880.
6. Chen, Y., Lomnitski, L., Michaelson, D.M. & Shohami, E. (1997) Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience, 80, 1255-1262.
7. Cheng, Y., Gidday, J.M., Yan, Q., Shah, A.R. & Holtzman, D.M. (1997) Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann. Neurol., 41(4), 521-529.
8. Cheng, Y., Deshmukh, M., D'Costa, A., Demaro, J.A., Gidday, J., Shah, A., Sun, Y., Jacquin, M.F., Johnson, E.M.J. & Holtzman, D.M. (1998) Caspase inhibitor affords neuroprotection with delayed adminstration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest., 101, 1992-1999.
9. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. & Pericak-Vance, M.A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261(5123), 921-923.
10. Fagan, A.M., Bu, G., Sun, Y., Daugherty, A. & Holtzman, D.M. (1996) Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem., 271, 30 121-30125.
11. Ferriero, D.M., Holtzman, D.M., Black, S.M. & Sheldon, R.A. (1996) Mice without neuronal nitric oxide synthase have less injury after perinatal hypoxia-ischemia. Neurobiol. Dis., 3, 64-71.
12. Friedman, G., Froom, P., Sazbon, L., Grinblatt, I., Shochina, M., Tsenter, J., Babaey, S., Yehuda, B. & Groswasser, Z. (1999) Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology, 52(2), 244-248.
13. Holtzman, D.M., Pitas, R.E., Kilbridge, J., Nathan, B., Mahley, R.W., Bu, G. & Schwartz, A.L. (1995) LRP mediates apolipoprotein E-dependent neurite outgrowth in a CNS-derived neuronal cell line. Proc. Natl. Acad. Sci. USA, 92, 9480-9484.
14. Holtzman, D.M. & Fagan, A.M. (1998) Potential role of apoE in structural plasticity in the nervous system: implications for diseases of the central nervous system. Trends Cardiovasc. Med., 8, 250-255.
15. Holtzman, D.M., Bales, K.R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A.M., Chang, L.K., Sun, Y. & Paul, S.M. (1999) Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J. Clin. Invest., 103(6), R15-R21.
16. Horsburgh, K., Graham, D.I., Stewart, J. & Nicoll, J.A. (1998) Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia. J. Neuropathol. Exp. Neurol, 58(3), 227-234.
17. Jordan, B.D., Relkin, N.R., Ravdin, L.D., Jacobs, A.R., Bennett, A. & Gandy, S. (1997) Apolipoprotein E epsilon-4 associated with chronic traumatic brain injury in boxing. JAMA, 278, 136-140.
18. Jordan, J., Galindo, M.F., Miller, R.J., Reardon, C.A. & Getz, G.S. (1998) Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal. J. Neuroscience, 18(1), 195-204.
19. Koh, J.Y., Yang, L.L. & Cotman, C.W. (1990) Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res., 533(2), 315-320.
20. Klingman, J.G., Hartley, D.M. & Choi, D.W. (1990) Automated determination of excitatory amino acid neurotoxicity in cortical culture. J. Neurosci. Meths, 31(1), 47-51.
21. LaDu, M.J., Gilligan, S.M., Lukens, S.R., Cabana, V.G., Reardon, C., Van Eldik, L.J. & Holtzman, D.M. (1998) Nascent astroctye particles differ from lipoproteins in CSF. J. Neurochem., 70, 2070-2081.
22. Laskowitz, D.T., Horsburgh, K. & Roses, A.D. (1998) Apolipoprotein E and the CNS response to injury. J. Cereb. Blood Flow Metab., 18(5), 465-471.
23. Lee, J.-M., Zipfel, G.J. & Choi, D.C. (1999) The changing landscape of ischaemic brain injury mechanisms. Nature, 399(Suppl.), A7-A14.
24. Lendon, C.L., Ashall, F. & Goate, A.M. (1997) Exploring the etiology of Alzheimer disease using molecular genetics. JAMA, 277, 825-831.
25. Ma, J., Brewer, H.B. Jr. & Potter, H. (1996) Alzheimer Abeta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by Abeta-related peptides. Neurobiol. Aging, 17, 773-780.
26. Marques, M.A., Tojar, M., Harmony, J.A. & Crutcher, K.A. (1996) A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. Neuroreport, 7(15-17), 2529-2532.
27. Masliah, E., Mallory, M., Alford, M. & Mucke, L. (1994) Abnormal synaptic regeneration in hAPP695 transgenic and apoE knockout mice. In Iqbal, K., Mortimer, J.A., Winblad, B. & Wisniewski, H.M. (eds) Research Advances in Alzheimer's Disease and Related Disorders. John Wiley, New York, pp. 405-414.
28. McDonald, J.W., Silverwstein, F.S. & Johnston, M.V. (1987) MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur. J. Pharmacol., 140, 359-361.
29. McCall, M.R., Forte, T.M. & Shore, V.G. (1988) Heterogeneity of nascent high density lipoproteins secreted by the hepatoma-derived cell line, Hep G2. J. Lipid Res., 29, 1127-1137.
30. McCarron, M.O. & Nicoll, J.A. (1998) High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage. Neurosci. Lett., 247(1), 45-48.
31. Miyata, M. & Smith, J.D. (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet., 14(1), 55-61.
32. Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W. & Pitas, R.E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science, 264, 850-852.
33. Nakai, M., Kawamata, T., Maeda, K. & Tanaka, C. (1996) Expression of apoE mRNA in rat microglia. Neurosci. Lett., 211, 41-44.
34. Nicoll, J.A., Roberts, G.W. & Graham, D.I. (1995) Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat. Med., 1(2), 135-137.
35. Parsadanian, A., Cheng, Y., Elliot, J., Gidday, J., Shah, A., Holtzman, D.M. & Snider, W. (1998) Overexpression of bcl-x in transgenic mice protects CNS neurons from apoptosis. J. Neuroscience, 18, 1009-1019.
36. Pitas, R.E., Boyles, J.K., Lee, S.H., Foss, D. & Mahley, R.W. (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta, 917(1), 148-161.
37. Pitas, R.E., Boyles, J.K., Lee, S.H., Hui, D. & Weisgraber, K.H. (1987b) Lipoproteins and their receptors in the central nervous system. J. Biol. Chem., 262, 14352-14360.
38. Poirer, J. (1994) Apolipoprotein E in animal models of CNS injury and Alzheimer's disease. Trends Neurol. Sci., 17, 525-530.
39. Rebeck, G.W., Reiter, J.S., Strickland, D.K. & Hyman, B.T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron, 11, 575-580.
40. Rose, K., Goldberg, M.P. & Choi, D.W. (1993) Cytotoxicity in murine neocortical cell culture. In Tyson, C.A. & Frazier, J.M. (eds), In Vitro Biological Methods: Methods in Toxicology. Academic Press, Inc., San Diego, pp. 46-60.
41. Roses, A.D. & Saunders, A.M. (1997) ApoE, Alzheimer's disease, and recovery from brain stress. Ann. N Y Acad. Sci., 826, 200-212.
42. Schmechel, D.E., Saunders, A.M., Strittmattter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D. & Roses, A.D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA, 90, 9649-9653.
43. Sheng, H., Laskowitz, D.T., Bennett, E., Schmechel, D.E., Bart, R.D., Saunders, A.M., Pearlstein, R.D., Roses, A.D. & Warner, D.S. (1998) Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J. Cereb. Blood Flow Metab., 18(4), 361-366.
44. Slooter, A.J., Tang, M.X., van Duijn, C.M., Stern, Y., Ott, A., Bell, K., Breteler, M.M., Van Broeckhoven, C., Tatemichi, T.K., Tycko, B., Hofman, A. & Mayeux, R. (1997) Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA, 277(10), 818-821.
45. Stone, D.J., Rozovsky, I., Morgan, T.E, Anderson, C.P., Hajian, H. & Finch, C.E. (1997) Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol., 143, 313-318.
46. Stone, D.J., Rozovsky, I., Morgan, T.E., Anderson, C.P. & Finch, C.E. (1998) Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J. Neuroscience, 18, 3180-3185.
47. Strittmatter, W., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. & Roses, A.D. (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA, 90, 8098-8102.
48. Strittmatter, W.J. & Roses, A.D. (1996) Apolipoprotein E and Alzheimer's disease. Ann. Rev. Neurosci., 19, 53-77.
49. Sun, Y., Wu, S., Bu, G., Onifade, M.K., Patel, S.N., LaDu, M.J., Fagan, A.M. & Holtzman, D.M. (1998) GFAP-apoE transgenic mice: astrocyte specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J. Neuroscience, 18, 3261-3272.
50. Tang, M.X., Maestre, G., Tsai, W.Y., Liu, X.H., Feng, L., Chung, W.Y., Chun, M., Schofield, P., Stern, Y., Tycko, B. & Mayeux, R. (1996) Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease. Ann. N Y Acad. Sci., 802, 6-15.
51. Teter, B., Harris-White, M.E., Frautschy, S.A. & Cole, G.M. (1999) Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures. Neuroscience, 91, 1009-1016.
52. Tolar, M., Marques, M.A., Harmony, J.A.K. & Crutcher, K.A. (1997) Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J. Neuroscience, 17, 5678-5686.
53. Vanucci, R.C. (1990) Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr. Res., 27, 317-326.
54. Xu, P.T., Schmechel, D., Rothrock-Christian, T., Burkhart, D.S., Qiu, H.L., Popko, B., Sullivan, P., Maeda, N., Saunders, A.M., Roses, A.D. & Gilbert, J.R. (1996) Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis., 3, 229-245.
55. Xu, P.T., Gilbert, J.R., Qiu, H.L., Ervin, J., Rothrock-Christian, T.R., Hulette, C. & Schmechel, D.E. (1999) Specific regional transcription of apolipoprotein E in human brain neurons. Am. J. Pathol., 154(2), 601-611.